Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

5-ARI therapy may help prevent prostate cancer progression.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Letrozole reduces seizures but not brain damage in mice.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Entospletinib effectively prevents eye and skin GVHD in mice.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Baricitinib is effective and safe for treating severe alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Oclacitinib maleate successfully treated alopecia in Andean bears.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Formononetin may help protect the brain and treat neurological diseases.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.